Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey

Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey
复制标题

DOI:
10.1016/j.sapharm.2020.07.006
复制
发表时间:
2021-01-01
影响因子:
3.9
通讯作者:
Hasan, Syed Shahzad
Hasan, Syed Shahzad
中科院分区:
医学3区
文献类型:
--
作者:
Zaidi, Syed Tabish R.;Hasan, Syed Shahzad

文献摘要

被引文献

相似文献

导言:冠状病毒病(covid - 19)对各种卫生服务的提供产生了不利影响。人们对covid - 19对英国各地药房服务的影响知之甚少。我们对英国各地的社区药剂师进行了调查,以了解他们在covid - 19大流行期间的保护措施、专业和一般福利以及药房服务的提供情况。方法:于2020年5月第二周通过全国药学服务谈判委员会和地方药学委员会每周通讯,邀请社区药师参加横断面调查。调查持续了4周。结果:共有206名药剂师回应了来自英格兰、北爱尔兰、苏格兰和威尔士的调查。大多数药剂师(75%或以上)报告说,他们药房的客流量有所增加,并且在向有流感样症状的患者提出相关问题之前,会向他们提供适当的护理。大多数药剂师(85%)与客户保持2米的安全距离,72%的药剂师佩戴N95防护口罩,28%的药剂师除使用安全距离和防护口罩外,还使用防护手套和围裙。99%的药剂师报告药物短缺,38%和26%的药剂师报告严重药物短缺和严重药物短缺造成非处方药以外的混乱。89%的药剂师报告了患者或护理人员的不当行为,31%和16%的药剂师分别报告说这是一个经常或经常出现的问题。53%的药剂师表示,如果提供适当的培训和报销,他们愿意为covid - 19抗体的大规模检测提供帮助。结论:社区药剂师在英国面临着相当大的挑战,在个人保护和药学服务的交付。患者和护理人员对社区药剂师的不当行为需要紧急关注,以确保所有社区药剂师有一个安全的工作场所。
Introduction: Coronavirus disease (COVID19) has adversely affected the delivery of various health services. Little is known about the impact of COVID19 on pharmacy services across the United Kingdom (UK). We surveyed community pharmacists across the UK to understand their protective practices, professional and general wellbeing, and the delivery of pharmacy services during the COVID19 pandemic.Methods: Community pharmacists were invited to participate in a cross-sectional survey via the nationwide weekly newsletter of Pharmaceutical Services Negotiating Committee and the local pharmaceutical committees during the second week of May 2020. The survey remained open for 4 weeks.Results: A total of 206 pharmacists responded to the survey with representations from England, Northern Ireland, Scotland, and Wales. The majority of pharmacists (>75% or above) reported an increase in customer traffic to their pharmacy and were asking relevant questions from patients with flu-like symptoms before signposting them to the appropriate care. Most pharmacists (>85%) were maintaining a safe distance of 2 m from customers and 72% were wearing an N95 protective mask and 28% were using protective gloves and apron in addition to safe distancing and protective masks. Ninety-nine percent of pharmacists reported drug shortages with 38% and 26% reported significant drug shortages and critical drug shortages causing disruptions beyond over the counter medicines. Eighty-nine percent pharmacists reported inappropriate behaviour from patients or carers with 31% and 16% reported it to be a regular or frequent problem, respectively. Fifty-three% of pharmacists were willing to offer their assistance for mass testing of COVID19 antibodies if adequate training and reimbursement are provided.Conclusion: Community pharmacists in the UK are facing considerable challenges in terms of personal protection and the delivery of pharmacy services. Inappropriate behaviour from patients and carers towards community pharmacists require urgent attention to ensure a safe working place for all community pharmacists.